Democritus University of Thrace (DUTH)
Κλινικές και εργαστηριακές παράμετροι και συνοσηρότητα σε ασθενείς με σύνδρομο αλληλοεπικάλυψης χρόνιας αποφρακτικής πνευμονοπάθειας και συνδρόμου αποφρακτικών απνοιών υποπνοιών κατά τον ύπνο: επίδραση της θεραπείας με μη επεμβατικό μηχανικό αερισμό θετικής πίεσης
Abstract
dc:descriptionIntroduction: Patients with overlap syndrome (OS), that is obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), are at increased risk of acute exacerbations related to COPD (AECOPD). Moreover, OS is associated with worse quality of life, more severe hypoxemia during sleep, increased number of comorbidities and worse survival compared to COPD or OSA alone. The first line treatment for OSA is CPAP, while bronchodilation is the cornerstone of COPD treatment. Although the role of bronchodilation therapy on the prevention and management of COPD exacerbations is known, data regarding the effect of CPAP compliance on COPD exacerbations in patients with OS are lacking. Aim of the study was to assess the effect of CPAP compliance on AECOPD, symptoms and pulmonary function in OS patients. Methods: Consecutive OS patients underwent assessment at baseline and at 12 months under treatment with CPAP of: AECOPD and hospitalizations, COPD Assessment Test (CAT) and modified British Medical Research Council (mMRC) questionnaires, pulmonary function testing and 6-min walking test (6MWT). Moreover, a follow-up at 6 months was performed to evaluate compliance to CPAP and to assess symptoms and pulmonary function. Results: In total, 59 patients (54 males) with OS were followed for 12 months and divided post hoc according to CPAP compliance into: group A with good (≥4 h CPAP use/night, n = 29) and group B with poor (<4 h CPAP use/night, n = 30) CPAP compliance. At baseline, patients in group A had a higher AHI (p = 0.007) and FEV1 (p = 0.007) and performed better at the 6MWT (p = 0.022), compared to patients in group B. Moreover, patients in group B had higher CAT score (p = 0.040) than patients in group A. There were no differences between groups in terms of mMRC score and GOLD stage classification. At 6 months group A had higher PaO2 [77 mmHg (71 – 81.5) vs. 68.5 mmHg (61.3 – 73.8), p=0.003) and lower levels of HCO3- [27.3 mmol/L (25.9 – 29.2) vs. 29.8 mmol/L (28 – 30.6), p=0.010] compared to group B. Moreover, group A presented a decrease in the CAT questionnaire [5 (4 – 7.5 vs. 8 (5 – 11), p=0.218)] and covered a longer distance in 6MWT compared to group B [480 (422.5 – 530) vs. 380 (262.3 – 540), p=0.139]. At 12 months, group A showed improvements in FEV1 (p = 0.024), total lung capacity (p = 0.024), RV/TLC (p = 0.003), 6MWT (p < 0.001) and CAT (p < 0.001). COPD exacerbations decreased in patients with good CPAP compliance from baseline to 12 months (17 before vs. 5 after, p = 0.001), but not in those with poor compliance (15 before vs. 15 after, p = 1). At multivariate regression analysis, COPD exacerbations were associated with poor CPAP compliance (β = 0.362, 95% CI: 0.075–0.649, p = 0.015). Conclusions: When compared to poorly compliant patients, OS patients with good CPAP compliance had a lower number of AECOPD and showed improved lung function and COPD related symptoms.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Voulgaris, Athanasios
- Βούλγαρης, Αθανάσιος
Subjects
dc:subject × 18- Χρόνια αποφρακτική πνευμονοπάθεια
- Αποφρακτική υπνική άπνοια
- Σύνδρομο αλληλοεπικάλυψης
- Συσκευή θετικής πίεσης του ανώτερου αεραγωγού
- Μη επεμβατικός μηχανικός αερισμός
- Παροξύνσεις ΧΑΠ
- Chronic obstructive pulmonary disease (COPD)
- Obstructive sleep apnea (OSA)
- Overlap syndrome (OVS)
- CPAP
- Non invasive ventilation
- COPD exacerbations
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Πνευμονολογία και Αναπνευστικές παθήσεις
- Clinical Medicine
- Medical and Health Sciences
- Pulmonary and Respiratory Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54171